Atlant Stability vs UBS Lux Equity Fund Biotech USD

Atlant Stability vs UBS Lux Equity Fund Biotech USD

1. Atlant Stability

  • Security

    Atlant Stability

  • Fee

    0.50%

  • ISIN

    SE0002623553

  • Holdings

    20

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 1 holdings in Atlant Stability, where the largest holding is (8.89), followed by (3.16) and (3.03). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Atlant Stability and UBS Lux Equity Fund Biotech USD.

Atlant Stability UBS Lux Equity Fund Biotech USD
1.
8.89 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2.
3.16 %
2. Vertex Pharmaceuticals Inc
9.35 %
3.
3.03 %
3. Moderna Inc
9.21 %
4.
2.86 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5.
2.42 %
5. AbbVie Inc
USA
5.53 %
6.
2.15 %
6. Gilead Sciences Inc
USA
4.66 %
7.
2.08 %
7. Amgen Inc
4.3 %
8.
1.98 %
8. BioNTech SE
4.13 %
9.
1.87 %
9. Karuna Therapeutics Inc
3.75 %
10.
1.76 %
10. Royalty Pharma Plc
3.37 %
11.
1.65 %
-
12.
1.65 %
-
13.
1.54 %
-
14.
1.49 %
-
15.
1.47 %
-
16.
1.46 %
-
17.
1.44 %
-
18.
1.4 %
-
19.
1.35 %
-
20.
1.31 %
-

The list of fund holdings was last updated on June 5, 2025.